| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Mar―06 |
Non-specific prevention of novel coronavirus infection in the workplace as a component of medical deontology |
EA Medvedeva, GG Marin, MV Chernogorova, IR Bakhareva |
| 2 |
[GO] |
2024―Jun―24 |
Comparative analysis of the adaptability of COVID-19 pandemic clinical trial protocols by several sponsors |
AL Khokholov, AA Eleskina, LM Belchik |
| 3 |
[GO] |
2022―Dec―15 |
Ethical issues of the off-label use of drugs for treatment of COVID-19 |
YaG Severova, NV Teplova |
| 4 |
[GO] |
2022―Mar―29 |
Drug repositioning: lessons from the COVID-19 pandemic |
VV Poroykov |
| 5 |
[GO] |
2022―Feb―08 |
Digitalization of healthcare and ethical challenges of COVID-19 pandemic |
FT Nezhmetdinova, ME Guryleva |
| 6 |
[GO] |
2021―Oct―15 |
Vaccination against Covid-19: contribution to therapy and prognosis |
MK Kartashova, YaV Kiseleva, MCh Semenistaya, ChS Pavlov |
| 7 |
[GO] |
2021―Apr―16 |
Ethical aspects of voluntary informed consent in vacсination against COVID-19 |
KV Zorin, KG Gurevich |
